First Time Loading...

ADMA Biologics Inc
NASDAQ:ADMA

Watchlist Manager
ADMA Biologics Inc Logo
ADMA Biologics Inc
NASDAQ:ADMA
Watchlist
Price: 6.6 USD -2.08% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. [ Read More ]

The intrinsic value of one ADMA stock under the Base Case scenario is 5.01 USD. Compared to the current market price of 6.6 USD, ADMA Biologics Inc is Overvalued by 24%.

Key Points:
ADMA Intrinsic Value
Base Case
5.01 USD
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ADMA Biologics Inc

Backtest ADMA Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ADMA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of ADMA Biologics Inc's business.

What risks and challenges
does ADMA Biologics Inc face in the near future?

Summarize the latest earnings report
of ADMA Biologics Inc.

Provide P/E
for ADMA Biologics Inc and its competitors.

Financials

Balance Sheet Decomposition
ADMA Biologics Inc

Current Assets 257m
Cash & Short-Term Investments 51.4m
Receivables 27.4m
Other Current Assets 178.2m
Non-Current Assets 72.2m
PP&E 63.5m
Intangibles 4m
Other Non-Current Assets 4.7m
Current Liabilities 49.8m
Accounts Payable 15.7m
Accrued Liabilities 31.1m
Other Current Liabilities 3.1m
Non-Current Liabilities 144.2m
Long-Term Debt 130.6m
Other Non-Current Liabilities 13.6m
Efficiency

Earnings Waterfall
ADMA Biologics Inc

Revenue
258.2m USD
Cost of Revenue
-169.3m USD
Gross Profit
88.9m USD
Operating Expenses
-67.3m USD
Operating Income
21.6m USD
Other Expenses
-49.9m USD
Net Income
-28.2m USD

Free Cash Flow Analysis
ADMA Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ADMA Profitability Score
Profitability Due Diligence

ADMA Biologics Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
Exceptional 1-Year Revenue Growth
34/100
Profitability
Score

ADMA Biologics Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

ADMA Solvency Score
Solvency Due Diligence

ADMA Biologics Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
Low D/E
46/100
Solvency
Score

ADMA Biologics Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ADMA Price Targets Summary
ADMA Biologics Inc

Wall Street analysts forecast ADMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADMA is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
8% Downside
Average
Price Target
8.16 USD
24% Upside
Highest
Price Target
10.5 USD
59% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ADMA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ADMA Price
ADMA Biologics Inc

1M 1M
+23%
6M 6M
+84%
1Y 1Y
+102%
3Y 3Y
+295%
5Y 5Y
+74%
10Y 10Y
-21%
Annual Price Range
6.6
52w Low
3.08
52w High
6.74
Price Metrics
Average Annual Return 22.61%
Standard Deviation of Annual Returns 96.1%
Max Drawdown -80%
Shares Statistics
Market Capitalization 1.5B USD
Shares Outstanding 228 220 000
Percentage of Shares Shorted 3.09%

ADMA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

ADMA Biologics Inc Logo
ADMA Biologics Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.5B USD

Dividend Yield

0%

Description

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey and currently employs 527 full-time employees. The company went IPO on 2013-10-17. The firm is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include ADMA BioManufacturing and Plasma Collection Centers. The Company’s ADMA BioManufacturing segment reflects its immune globulin manufacturing and development operations in Florida. The Plasma Collection Centers segment consists of approximately three plasma collection facilities. Its products include BIVIGAM, ASCENIV and Nabi-HB. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons.

Contact

NEW JERSEY
Ramsey
C/O Adma Biologics, Inc., 465 State Route 17
+12014785552.0
https://www.admabiologics.com/

IPO

2013-10-17

Employees

527

Officers

Co-Founder, President, CEO & Director
Mr. Adam S. Grossman
Co-Founder & Vice Chairman of the Board
Dr. Jerrold B. Grossman D.P.S., Ph.D.
Executive VP, CFO & GM of ADMA BioCenters
Mr. Brian Lenz CPA
Senior Vice President of Compliance & Project Operations
Ms. Kaitlin Kestenberg
Vice President of Marketing & Corporate Development
Mr. Drew Pantello
Vice President of Sales
Mr. Neal C. Fitzpatrick
Show More
Executive Director of Human Resources
Ms. Cindy Petersen
Senior Director of Business Development & Corporate Strategy
Mr. Skyler Bloom
Show Less

See Also

Discover More
What is the Intrinsic Value of one ADMA stock?

The intrinsic value of one ADMA stock under the Base Case scenario is 5.01 USD.

Is ADMA stock undervalued or overvalued?

Compared to the current market price of 6.6 USD, ADMA Biologics Inc is Overvalued by 24%.